
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Brizo
Therapeutic Area : Urology
Study Phase : Undisclosed
Sponsor : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Brizo is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Prostatic Hyperplasia.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 07, 2022
Lead Product(s) : Brizo
Therapeutic Area : Urology
Highest Development Status : Undisclosed
Sponsor : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Femarelle
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Recipient : Dr. Lila Nachtigall Rapid Medical Research, New York
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Femarelle is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 30, 2011
Lead Product(s) : Femarelle
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Recipient : Dr. Lila Nachtigall Rapid Medical Research, New York
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Femarelle
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable
A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms
Details : Femarelle is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 05, 2010
Lead Product(s) : Femarelle
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable
